Related Experiment Video
Updated: Feb 19, 2026
08:22
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
3.5K
Summary
Hypothyroidism negatively impacts heart function and increases cardiovascular risk. Treatment for subclinical hypothyroidism in heart patients is most beneficial for those under 65, with risks often outweighing benefits in older individuals.
Area of Science:
- Cardiology
- Endocrinology
- Internal Medicine
Background:
- Hypothyroidism is prevalent in heart disease patients, acting as a risk factor for atherosclerosis and ischemic heart disease.
- It directly impairs left and right ventricular function, leading to hypothyroidism-induced cardiomyopathy.
- Thyroid peroxidase antibodies are often implicated.
Purpose of the Study:
- To evaluate the management of hypothyroidism, particularly subclinical hypothyroidism, in patients with heart disease.
- To determine the age-dependent efficacy and risks of levothyroxine replacement therapy.
- To guide treatment decisions based on patient age and cardiovascular risk profile.
Main Methods:
- Review of current clinical practices and literature regarding hypothyroidism management in cardiac patients.
- Analysis of the benefits and risks of levothyroxine therapy in different age groups.
- Assessment of thyroid stimulating hormone (TSH) level targets in heart disease patients.
Main Results:
- Manifest hypothyroidism requires levothyroxine replacement, initiated at low doses and titrated carefully in cardiac patients.
- Treatment of subclinical hypothyroidism in heart disease patients yields controversial benefits, highly dependent on age.
- For younger patients (<65 years), therapy is generally effective; for older patients (>80 years), risks often exceed benefits.
Conclusions:
- Levothyroxine therapy for manifest hypothyroidism is standard in cardiac patients, requiring cautious dose escalation.
- Subclinical hypothyroidism treatment in heart disease is most effective in younger individuals.
- In elderly patients (>80 years), conservative management of subclinical hypothyroidism is preferred due to elevated risks.
Related Concept Videos
01:27Heart Failure I: Introduction
987
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
987
01:30Heart Failure VII: Nursing Interventions
559
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
559
01:26Heart Failure III: Clinical Manifestations
658
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
658
01:22Heart Failure VI: Adjunct Therapies
417
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
417
01:22Heart Failure Drugs: β-Blockers
986
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
986
01:20Rheumatic Heart Disease IV: Nursing Management
361
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
361